Female Sexual Dysfunction Treatment Market Size to grow by USD 21691.6 million between 2024-2028
According to a research report “ Female Sexual Dysfunction Treatment Market” by Age Group (Above 40 years, Below 40 years) Product (Non-hormonal therapy, Hormonal therapy) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 21691.6 million, at a CAGR of about 51.9% during the forecast period. The global female sexual dysfunction treatment market experiences significant growth due to the increasing prevalence of chronic diseases among women. Chronic conditions such as diabetes, cardiovascular disorders, and cancer increase the risk of sexual dysfunction, leading to a higher demand for effective treatment solutions. Additionally, factors like hormonal imbalances, aging, and medication use contribute to the prevalence of sexual dysfunction. Effective treatment options are essential to address this growing health concern.
Browse market data tables, figures, and in-depth TOC on “Female Sexual Dysfunction Treatment Market” by Age Group (Above 40 years, Below 40 years) Product (Non-hormonal therapy, Hormonal therapy) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Age Group, the Above 40 years segment is projected to dominate the market size in 2024
The Female Sexual Dysfunction (FSD) treatment market represents a significant business opportunity, driven by the growing prevalence of FSD and increasing awareness of available therapeutic options. Key players in this sector focus on developing innovative solutions to address the complex nature of FSD, leveraging advanced technologies and research to improve treatment efficacy and patient outcomes. Market growth is further fueled by regulatory support and expanding healthcare coverage for sexual health services.
By Product, Non-hormonal therapy segment is expected to hold the largest market size for the year 2024
The Female Sexual Dysfunction (FSD) treatment market represents a significant business opportunity, driven by the growing prevalence of FSD and increasing awareness of available therapeutic options. Key players in this sector focus on developing innovative solutions to address the complex nature of FSD, leveraging advanced technologies and research to improve treatment efficacy and patient outcomes. Market growth is further fueled by regulatory support and expanding healthcare coverage for sexual health services.
North America is forecasted to hold the largest market size by region in 2024
The Female Sexual Dysfunction (FSD) treatment market represents a significant business opportunity, driven by the growing prevalence of FSD and increasing awareness of available therapeutic options. Key players in this sector focus on developing innovative solutions to address the complex nature of FSD, leveraging advanced technologies and research to improve treatment efficacy and patient outcomes. Market growth is further fueled by regulatory support and expanding healthcare coverage for sexual health services.
The Female Sexual Dysfunction Treatment Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Female Sexual Dysfunction (FSD) Treatment Market encompasses a range of interventions aimed at addressing various sexual health issues experienced by women. These issues may include, but are not limited to, pelvic floor dysfunction, orgasmic disorders, arousal difficulties, and reduced sexual desire. Treatment modalities for FSD may involve pharmacological interventions such as phosphodiesterase inhibitors and medications, hormonal therapy, and psychotherapy. Factors contributing to FSD are diverse and may include cardiovascular disorders, cancer, chronic diseases, depression, age, hormonal changes, estrogen concentrations, pain, and stress and anxiety. Menopausal women and those with gynecological disorders are particularly susceptible to these issues. Healthcare organizations play a crucial role in providing comprehensive care for women experiencing FSD, addressing both the physical and emotional aspects of their sexual health.
Market Research Overview
The Female Sexual Dysfunction (FSD) Treatment Market encompasses a range of therapeutic approaches for addressing various sexual health issues experienced by women. These approaches include dietary therapy, herbal medicine, acupuncture, and evidence-based practices at academic centers and research institutions. Healthcare professionals such as psychologists, sex therapists, physical therapists, gynecologists, and sexologists offer counseling and specialized care for conditions like orgasmic response, sexual functioning, and fulfillment. Modern facilities and advanced medical technology in healthcare infrastructure house pharmacological treatments like ospemifene, bremelanotide, flibanestrin, and medications for dyspareunia segment, clinical trials, and non-estrogen therapies. Topical, parenteral, oral, and telemedicine services provide accessibility to treatments for women dealing with interpersonal difficulties, hormonal changes, pain, and sexual response issues. Societal taboos surrounding women's health and sexuality necessitate education and counseling, sexual health testing, and couples therapy. Pelvic floor exercises, phosphodiesterase inhibitors, and hormonal therapy are among the treatments available for gynaecological conditions, malignant diseases, hypertension, diabetes mellitus, chronic conditions, and post-menopausal women. Online pharmacies, drug stores, and hospital pharmacies offer various treatments, including testosterone creams, topical estrogen products, vaginal tablets, and conjugated estrogen creams. Anti-hypertensive drugs and antidepressants are used to treat conditions like vaginismus and vulvovaginal atrophy infections. Healthcare organizations focus on providing high-quality care for cardiovascular disease, diabetes, chronic diseases, depression, age, and hormonal changes. The market continues to evolve, integrating advanced medical technology and lifestyle modifications to improve female sexual health.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
